Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating nivolumab in patients with localized kidney cancer undergoing nephrectomy; status ACTIVE_NOT_RECRUITING with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-25